Chemistry:Tropanserin

From HandWiki
Revision as of 18:39, 18 July 2022 by imported>Dennis Ross (correction)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Tropanserin
Tropanserin.svg
Clinical data
ATC code
  • None
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC17H23NO2
Molar mass273.376 g·mol−1
3D model (JSmol)

Tropanserin (INN; MDL-72,422) is a drug which acts as a potent and selective 5-HT3 receptor antagonist.[1] It was investigated in clinical trials for the treatment of migraine in the 1980s but was never marketed.[2]

Synthesis

Tropanserin can be prepared by the reaction of tropine with 3,5-dimethylbenzoyl chloride.

Tropanserin synthesis[3]

See also

References

  1. 5-Hydroxytryptamine-3 Receptor Antagonists. CRC Press. 22 October 1993. p. 244. ISBN 978-0-8493-5463-2. https://books.google.com/books?id=YSUAQFAga3oC&pg=PA244. Retrieved 6 May 2012. 
  2. "Recent Advances in Migraine Research". Annual Reports in Medicinal Chemistry. 22. Academic Press. 1 August 1987. p. 44. doi:10.1016/S0065-7743(08)61153-7. ISBN 978-0-08-058366-2. https://books.google.com/books?id=oJeTSJveeuAC&pg=PA44. 
  3. Fozard JR, Gittos MW, "Treatment of migraine with substituted tropyl benzoate derivatives", US patent 4563465, issued 7 January 1986, assigned to Merrell Dow Pharma